Terumo Nanopass Pen Needle 34g x 100

Terumo Nanopass Pen Needle 34g x 100Terumo Nanopass Pen Needle 34g x 100 NANOPASS 34 is 22% thinner than 32G. Pain is primarily related to needle thickness. There are 100 200 pain receptors per cm_ human skin surface. NANOPASS 34 decreases the probability of touching the pain receptors and therefore makes the insulin injection virtually painless. NANOPASS 34 causes less skin trauma than larger needle sizes, which results in less pain. The unique asymmetric edge of NANOPASS cuts the skin

Terumo Nanopass Pen Needle 34g x 100

NANOPASS 34 is 22% thinner than 32G.

• Pain is primarily related to needle thickness. There are 100-200 pain receptors per cm_ human skin surface. NANOPASS 34 decreases the probability of touching the pain receptors and therefore makes the insulin injection virtually painless.
• NANOPASS 34 causes less skin trauma than larger needle sizes, which results in less pain.
• The unique asymmetric edge of NANOPASS cuts the skin instead of puncturing it.
• This decreases the resistance while penetrating the skin. Another step towards virtually painless insulin injection.
• The patented slim double tapered needle shape reduces the insulin injection force significantly.
• Although the needle tip is 34G, NANOPASS 34 provides less injection force than a conventional 32G pen needle.
• NANOPASS 34 combines virtually painless injection with easy handling.

• Needle tip diameter: 34G (0.18mm)
• Needle length: 4mm